Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
57.51
-1.22 (-2.08%)
Mar 31, 2025, 10:01 AM EDT - Market open
Bio-Techne Employees
Bio-Techne had 3,050 employees as of June 30, 2023. The number of employees increased by 50 or 1.67% compared to the previous year.
Employees
3,050
Change (1Y)
50
Growth (1Y)
1.67%
Revenue / Employee
$392,136
Profits / Employee
$51,837
Market Cap
9.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECH News
- 5 days ago - Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany - PRNewsWire
- 7 days ago - Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - PRNewsWire
- 21 days ago - Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System - PRNewsWire
- 4 weeks ago - Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes - PRNewsWire
- 4 weeks ago - Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain - Seeking Alpha
- 4 weeks ago - Bio-Techne to Present at Investor Conferences - PRNewsWire
- 5 weeks ago - Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology - PRNewsWire
- 5 weeks ago - Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System - PRNewsWire